πŸ‡ΊπŸ‡Έ FDA

Intelligence Β· Clinical Pipeline

R&D Pipeline Programs

ClinicalTrials.gov programs linked to pharma sponsors β€” phase, modality, and trial IDs for BD and competitive intelligence.

Programs indexed
20,548
Companies
1,769
Drugs tracked
4,797

Quick answer

NovaPharmaNews tracks 20,548 pharmaceutical R&D pipeline programs sourced from ClinicalTrials.gov, linked to sponsor companies. Each profile includes development phase, modality, trial status, NCT identifiers, and indication text β€” searchable for business development and competitive intelligence.

1,413 results for β€œChinese” Clear

  1. oxytocin

    Xiyuan Hospital of China Academy of Chinese Medical Sciences

    Healthy

    phase 1 small molecule active

    6 trials

  2. peficitinib

    Xiyuan Hospital of China Academy of Chinese Medical Sciences

    Healthy Volunteers

    phase 1 small molecule completed

    1 trial

  3. randomized, double-blinded, placebo-controlled

    Xiyuan Hospital of China Academy of Chinese Medical Sciences

    Prevention of COVID-19 Caused by SARS-CoV-2

    phase 1 mab active

    1 trial

  4. shenhuang granule

    Xiyuan Hospital of China Academy of Chinese Medical Sciences

    Sepsis

    phase 1 small molecule active

    1 trial

  5. standard chemotherapy medicine combined with Chinese herbs

    The First People's Hospital of Lianyungang

    Carcinoma, Non-Small-Cell Lung

    phase 1 small molecule active

    1 trial

  6. tirofiban in PV

    Xiyuan Hospital of China Academy of Chinese Medical Sciences

    Coronary Artery Disease

    phase 1 small molecule active

    1 trial

  7. transcutaneous auricular vagus nerve stimulation

    Xiyuan Hospital of China Academy of Chinese Medical Sciences

    Healthy Participants

    phase 1 other active

    1 trial

  8. uCD7 CART

    Xiyuan Hospital of China Academy of Chinese Medical Sciences

    Acute Myeloid Leukemia (AML)

    phase 1 mab active

    1 trial

  9. ucMSCs

    Xiyuan Hospital of China Academy of Chinese Medical Sciences

    Bronchopulmonary Dysplasia

    phase 1 mab active

    1 trial

  10. 0.3% ropivacaine and 50 ΞΌg dexmedetomidine

    Xiyuan Hospital of China Academy of Chinese Medical Sciences

    Free Flap Reconstruction

    approved small molecule active

    1 trial

  11. 0.9% Sodium Chloride Injection

    Xiyuan Hospital of China Academy of Chinese Medical Sciences

    Unstable Angina

    approved small molecule active

    1 trial

  12. 20 Β΅g recombinant hepatitis B vaccine at months 0, 1, and 6

    Xiyuan Hospital of China Academy of Chinese Medical Sciences

    Hepatitis B Vaccine

    approved mab active

    3 trials

  13. 23-valent pneumococcal polysaccharide vaccine

    Xiyuan Hospital of China Academy of Chinese Medical Sciences

    Vaccination

    approved mab completed

    1 trial

  14. 30% Oxygen

    Xiyuan Hospital of China Academy of Chinese Medical Sciences

    Atelectasis

    approved small molecule completed

    1 trial

  15. 30%Oxygen

    Xiyuan Hospital of China Academy of Chinese Medical Sciences

    Atelectasis, Postoperative

    approved small molecule completed

    1 trial

  16. 60 Β΅g dose hepatitis B vaccine

    Xiyuan Hospital of China Academy of Chinese Medical Sciences

    Hepatitis B Vaccination

    approved mab completed

    1 trial

  17. 60 Β΅g dose hepatitis B vaccine

    Xiyuan Hospital of China Academy of Chinese Medical Sciences

    Hepatitis B Vaccine

    approved mab completed

    1 trial

  18. 80% Oxygen

    Xiyuan Hospital of China Academy of Chinese Medical Sciences

    Oxygenation Index

    approved small molecule active

    1 trial

  19. ACEI / ARB+finerenone

    Xiyuan Hospital of China Academy of Chinese Medical Sciences

    Henoch SchΓΆnlein Purpura Nephritis

    approved small molecule active

    1 trial

  20. ATRA+Arsenic

    Xiyuan Hospital of China Academy of Chinese Medical Sciences

    Acute Promyelocytic Leukemia

    approved small molecule active

    1 trial

  21. Adefovir

    Xiyuan Hospital of China Academy of Chinese Medical Sciences

    Hepatitis B, Chronic

    approved small molecule completed

    1 trial

  22. Alendronate

    Xiyuan Hospital of China Academy of Chinese Medical Sciences

    Osteogenesis Imperfecta

    approved small molecule completed

    1 trial

  23. Amlodipine, Telmisartan, Amiloride Compound , Simvastatin

    Chinese University of Hong Kong

    Essential Hypertension

    approved small molecule active

    1 trial

  24. Anerning particle

    Xiyuan Hospital of China Academy of Chinese Medical Sciences

    Community-acquired Pneumonia

    approved small molecule active

    1 trial

Frequently asked questions

What is the NovaPharmaNews pipeline directory?

It is a searchable index of 20,548 clinical development programs grouped by sponsor company, with phase (Phase 1–3), modality, trial status, and linked NCT IDs from ClinicalTrials.gov.

Where does pipeline data come from?

Program records are derived from ClinicalTrials.gov and linked to NovaPharmaNews company profiles. Trial status and phase reflect registry data at last sync β€” verify on ClinicalTrials.gov before investment or partnering decisions. See our data sources page for attribution.

How do I find pipeline programs by company or phase?

Use the search box to match program name, indication, company name, or slug. Results are ordered with late-stage (Phase 3) programs first. Open any row to view the full program profile under its sponsor company.

Data attribution and licensing: Data sources